These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 3784305)
41. Effects of aluminum hydroxide on fluoride and calcium metabolism. Spencer H; Kramer L; Osis D; Wiatrowski E J Environ Pathol Toxicol Oncol; 1985; 6(1):33-41. PubMed ID: 4067833 [TBL] [Abstract][Full Text] [Related]
42. The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats. Matsuo A; Iida A; Tanimoto M; Matsushita M; Miyamoto K Ren Fail; 2014 Sep; 36(8):1291-7. PubMed ID: 24975675 [TBL] [Abstract][Full Text] [Related]
43. The regulation of calcitriol by parathyroid hormone and absorbed dietary phosphorus in subjects with moderate chronic renal failure. Prince RL; Hutchison BG; Dick I Metabolism; 1993 Jul; 42(7):834-8. PubMed ID: 8393953 [TBL] [Abstract][Full Text] [Related]
44. Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study. Delmez JA; Kelber J; Norword KY; Giles KS; Slatopolsky E Kidney Int; 1996 Jan; 49(1):163-7. PubMed ID: 8770963 [TBL] [Abstract][Full Text] [Related]
45. Phosphate binders do not compromise the copper status of adult renal disease patients on hemodialysis. Yates LA; Soffer O; Gropper SS Biol Trace Elem Res; 2000 Jul; 76(1):1-12. PubMed ID: 10999426 [TBL] [Abstract][Full Text] [Related]
46. Effects of high CaCO3 supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment. Gonella M; Calabrese G; Vagelli G; Pratesi G; Lamon S; Talarico S Clin Nephrol; 1985 Sep; 24(3):147-50. PubMed ID: 4042444 [TBL] [Abstract][Full Text] [Related]
47. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. Masuyama R; Nakaya Y; Katsumata S; Kajita Y; Uehara M; Tanaka S; Sakai A; Kato S; Nakamura T; Suzuki K J Bone Miner Res; 2003 Jul; 18(7):1217-26. PubMed ID: 12854831 [TBL] [Abstract][Full Text] [Related]
48. Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. Salusky IB; Coburn JW; Foley J; Nelson P; Fine RN J Pediatr; 1986 May; 108(5 Pt 1):767-70. PubMed ID: 3701525 [TBL] [Abstract][Full Text] [Related]
49. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients. Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674 [TBL] [Abstract][Full Text] [Related]
50. Calcium carbonate. A better phosphate binder than aluminum hydroxide. Lerner A; Kramer M; Goldstein S; Caruana R; Epstein S; Raja R ASAIO Trans; 1986; 32(1):315-8. PubMed ID: 3535845 [No Abstract] [Full Text] [Related]
51. Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus. Brickman AS; Hartenbower DL; Norman AW; Coburn JW Am J Clin Nutr; 1977 Jul; 30(7):1064-9. PubMed ID: 879073 [No Abstract] [Full Text] [Related]
52. Control of parathyroid function in patients with a short history of hemodialysis. Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904 [TBL] [Abstract][Full Text] [Related]
53. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)]. Novikov AI Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540 [No Abstract] [Full Text] [Related]
54. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. Spiegel DM; Farmer B; Smits G; Chonchol M J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314 [TBL] [Abstract][Full Text] [Related]
56. Effects of dietary phosphorus and calcium on the intestinal absorption of Ca in sheep. Abdel-Hafeez HM; MaƱas-Almendros M; Ross R; Care AD; Marshall DH Br J Nutr; 1982 Jan; 47(1):69-77. PubMed ID: 6800401 [TBL] [Abstract][Full Text] [Related]
57. Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients. Coyne DW; Grieff M; Ahya SN; Giles K; Norwood K; Slatopolsky E Am J Kidney Dis; 2002 Dec; 40(6):1283-8. PubMed ID: 12460048 [TBL] [Abstract][Full Text] [Related]
58. Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation. Barsotti G; Cupisti A; Morelli E; Meola M; Cozza V; Barsotti M; Giovannetti S Nephron; 1998; 79(2):137-41. PubMed ID: 9647491 [TBL] [Abstract][Full Text] [Related]
59. The effect of 1-alpha-hydroxycholecalciferol on calcium and phosphorus metabolism in the lactating ewe. Braithwaite GD Br J Nutr; 1978 Sep; 40(2):387-92. PubMed ID: 698176 [TBL] [Abstract][Full Text] [Related]
60. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. Slatopolsky E; Weerts C; Lopez-Hilker S; Norwood K; Zink M; Windus D; Delmez J N Engl J Med; 1986 Jul; 315(3):157-61. PubMed ID: 3724805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]